Novel therapeutic strategies for advanced ovarian cancer by using induced pluripotent stem cell‐derived myelomonocytic cells producing interferon beta-Reference-Cited by-同舟云学术

Novel therapeutic strategies for advanced ovarian cancer by using induced pluripotent stem cell‐derived myelomonocytic cells producing interferon beta

Published:2018-10-24 Issue:11 Volume:109 Page:3403-3410
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Imamura Yuko¹²,Tashiro Hironori³,Tsend‐Ayush Gandolgor¹^ORCID,Haruta Miwa²,Dashdemberel Narantuya¹,Komohara Yoshihiro⁴^ORCID,Tsuboki Junko¹,Takaishi Kiyomi¹,Ohba Takashi¹,Nishimura Yasuharu²⁵,Katabuchi Hidetaka¹,Senju Satoru²

Affiliation:

1. Department of Obstetrics and Gynecology Faculty of Life Sciences Kumamoto University Kumamoto Japan

2. Department of Immunogenetics Graduate School of Medical Sciences Kumamoto University Kumamoto Japan

3. Department of Mother‐Child Nursing Faculty of Life Sciences Kumamoto University Kumamoto Japan

4. Department of Cell Pathology Graduate School of Medical Sciences Kumamoto University Kumamoto Japan

5. Nishimura Project Laboratory Institute of Resource Development and Analysis Kumamoto University Kumamoto Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.13775

Reference23 articles.

1. Global cancer statistics, 2012

2. Carcinoma of the Ovary

3. Treatment options in recurrent ovarian cancer: latest evidence and clinical potential

4. Involvement of M2-polarized macrophages in the ascites from advanced epithelial ovarian carcinoma in tumor progression via Stat3 activation

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors;Stem Cell Reviews and Reports;2023-09-27

2. Reprogramming iPSCs to study age-related diseases: Models, therapeutics, and clinical trials;Mechanisms of Ageing and Development;2023-09

3. The role of interferons in ovarian cancer progression: Hinderer or promoter?;Frontiers in Immunology;2022-12-21

4. Friend and foe: the regulation network of ascites components in ovarian cancer progression;Journal of Cell Communication and Signaling;2022-10-13

5. Development of HLA-modified induced pluripotent stem cell-derived dendritic cells for a novel cancer immunotherapy;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2022-09